Proof of Principle: Phase I - Spring 2009 Priority Announcement (Drug Development) – Funding Decisions Notification (April 2009 Competition: 200904PDD)
(Alternate Title: Proof of Principle Program Phase I - Drug Development)The Canadian Institutes of Health Research (CIHR) is pleased to announce the results of the Proof of Principle: Phase I - Spring 2009 Priority Announcement (Drug Development) competition.
Funding Opportunity Summary
The objectives of the funding opportunity "Proof of Principle: Phase I - Spring 2009 Priority Announcement (Drug Development)" were to facilitate the advancement of promising drug compounds discovered in academia, focusing on:
- target validation
- lead compound validation
- lead compound optimization
Funding Competition Summary
A total of 9 applications were received of which 3 were approved for funding.
Contact Information
For further information about this competition, please contact:
Edit Palencsar
Program Delivery Coordinator
Canadian Institutes of Health Research
Telephone: 613-946-0095
Fax: 613-954-1800
Email: edit.palencsar@cihr-irsc.gc.ca
For further information about this initiative and the objectives of this funding opportunity please contact:
Chaidwick Leneis
Senior KSE Specialist
Knowledge Synthesis and Exchange Branch
Canadian Institutes of Health Research
Telephone: 613-941-4437
Fax: 613-954-1800
Email: chaidwick.leneis@cihr-irsc.gc.ca
Funding Decisions Data Report
Access the "Proof of Principle Program Phase I - Drug Development" funding decisions data report.